Gambro Healthcare, Inc. Recieves Subpoena in the US

Gambro Healthcare, Inc., Receives Subpoena in the US Stockholm, Sweden, June 20, 2001 - Gambro AB (OM Stockholm Exchange: GAMBaST, GAMBbST), a leading international medical technology and healthcare company, today announced that its wholly owned US subsidiary, Gambro Healthcare, Inc., received on June 18, 2001 a subpoena from the United States Department of Justice requesting information concerning Gambro Healthcare, Inc.'s, business activities and operations as part of an investigation by the US Attorney's office in St. Louis, Missouri. Gambro Healthcare, Inc., intends to respond appropriately to the request for information as required by the Department of Justice. Gambro has no further information concerning this matter at this time. For further information please contact: Bengt Modéer, Investor Relations, tel. +46-8-613-6533, +46-70-513-6533 Karin Avasalu, Corporate Communications, tel. +46-8-613-6500, +46-70-513- 6599 Kevin Smith, Investor Relations US, tel. +1-303-231-4750 ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.bit.se/bitonline/2001/06/20/20010620BIT00260/bit0002.doc http://www.bit.se/bitonline/2001/06/20/20010620BIT00260/bit0002.pdf

About Us

Gambro is a global medical technology and healthcare company with leading positions in renal care - services and products - and blood component technology. The group, with revenue of approximately SEK 18 billion (USD 2.2 billion), has approximately 17,000 employees in some 40 countries.

Subscribe